Wine and oxidative stress: Up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 297-304

  Covas, María Isabel ^a   Gambert, Philippe ^b   Fitó, Montserrat ^a   de la Torre, Rafael ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

DNA oxidation; LDL oxidation; Oxidative damage; Polyphenols; Wine

Indexed keywords

ALCOHOL; CAFFEINE; CATECHIN; PLACEBO; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CLINICAL TRIAL; DIETARY INTAKE; DNA DAMAGE; HUMAN; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RED WINE; REVIEW;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; DNA; FEMALE; FLAVONOIDS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OXIDANTS; OXIDATIVE STRESS; PHENOLS; WINE;

EID: 74949084835     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.031     Document Type: Review

References (70)

1. Covas M.I. The mediterranean diet and the role of alcohol. In: Victor R., Preedy, Ronald R., and Watson (Eds). Compressive handbook of alcohol related pathology (2004), Elsevier Science 135-146 [Chapter 12]
2. Bertelli A.A.E. Wine, research and cardiovascular disease: instructions for use. Atherosclerosis 195 (2007) 242-247
3. Rodríguez Artalejo F., Banegas J.R., García Colmenero C., and del Rey Calero J. Lower consumption of wine and fish as a possible explanation for higher ischemic heart disease mortality in Spain's Mediterranean region. Int J Epidemiol 25 (1996) 1196-1201
4. Tunstall-Pedoe H., Kuulasma K., Mahonen M., et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353 (1999) 1547-1557
5. Schröder H., Marrugat J., Fitó M., Weinbrenner T., and Covas M.I. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein. Free Rad Biol Med 40 (2006) 1474-1481
6. Yoshida R., Shioji I., Kishida A., and Ogawa Y. Moderate alcohol consumption reduces urinary 8-hydroxydeoxyguanosine by inducing of uric acid. Ind Health 39 (2001) 322-329
7. Barden A., Zilkens R.R., Croft K., et al. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Rad Biol Med 42 (2007) 1730-1735
8. Hartman T.J., Baer D.J., Graham L.B., et al. Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. Eur J Clin Nutr 59 (2005) 161-168
9. Beulens J.W.J., Van der Berg R., Kok F.J., et al. Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity. Nutr Met Cardiovasc Dis 18 (2008) 539-544
10. Videla L.A., and Valenzuela A. Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications. Life Sci 31 (1987) 2395-2407
11. Woolf S.H., Battista R.N., Anderson G.M., Logan A.G., and Wang E. Assessing the clinical effectiveness of preventive manoeuvres: analytic principals and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol 43 (1990) 891-905
12. Witzum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
13. Cooke M.S., Evans M.D., Dizdaroglou M., and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17 (2003) 1195-1214
14. Andreassi M.A. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat Res 543 (2003) 67-68
15. Nagata K., Suzuki H., and Sakaguchi S. Common pathogenic mechanisms in the development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 32 (2007) 453-468
16. Catapano A.L. Antioxidant effects of flavonoids. Angiology 48 (1997) 39-41
17. Modun D., Music I., Vukovic J., et al. The increase in human plasma antioxidant capacity after red wine consumption is due to both plasma urate and wine polyphenols. Atherosclerosis 197 (2008) 250-256
18. Devaraj S., Vega-López S., Kaul N., et al. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the lipoprotein profile. Lipids 37 (2002) 931-934
19. Covas M.I., Nyyssönen K., Poulsen H.E., et al. The effect of polyphenols in olive oil on heart disease risk factors. Ann Int Med 145 (2006) 333-341
20. Ansell B.J., Watson K.E., Fogelman A.M., et al. High-density lipoprotein function. Recent advances. J Am Coll Cardiol 46 (2005) 1792-1798
21. Gouédard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Moll Cell Biol 24 (2004) 5209-5222
22. Nielsen S.E., Young J.F., Daneshvar B., et al. Effect of parsley (Petroselium crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress. Br J Nutr 81 (1999) 447-455
23. Hadi S.M., Bhat S.H., Azmi A.S., et al. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol 17 (2007) 370-376
24. Vinson J.A., and Hontz B.A. Phenol antioxidant index: comparative antioxidant effectiveness of red and white wines. J Agric Food Chem 43 (1995) 401-403
25. German J.B., and Walzem R.L. The health benefits of wine. Annu Rev Nutr 20 (2000) 561-593
26. Ursini F., Zamburlini A., Cazzolato G., et al. Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic Biol Med 25 (1998) 250-252
27. Bub A., Wtzl B., Heeb D., Rechkemmer G., and Briviba K. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur J Nutr 40 (2001) 113-120
28. De Vries J.H.M., Hollman P.C.H., Van Amersfoort I., Olyhof M.R., and Katan M.B. Red wine is a poor source of bioavailable phenol in men. J Nutr 131 (2001) 745-748
29. Donovan J.L., Bell J.R., Kasim-Karakas S., et al. Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129 (1999) 1662-1668
30. Pignatelli P., Ghiselli A., Buchetti B., et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 (2006) 77-83
31. Vitaglione P., Sforza S., Galaverna G., et al. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49 (2005) 495-504
32. Urpi-Sardà M., Zamora-Ros R., Lamuela-Raventós R., et al. HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin Chem 53 (2007) 292-299
33. Cartron E., Fouret G., Carbonneau M.A., et al. Red-wine beneficial long term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine. Description of two O-methylated derivatives of gallic acid in humans. Free Rad Res 37 (2003) 1021-1035
34. Zamora-Ros R., Urpí-Sardà M., Lamuela-Raventós R., et al., The PREDIMED study. Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects. Free Radic Bio Med 46 (2009) 1562-1566
35. Day A.J., Bao Y., Morgan M.R.A., and Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29 (2000) 1234-1243
36. Santner S.J., Fiel P.D., and Santen R.J. In situ estrogen production via estrone sulphatase pathway in breast tumours: relative importance versus aromatase pathway. J Clin Endocrinol Metab 50 (1984) 29-33
37. Shimoi K., Saka N., Nozawa R., et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 29 (2001) 1521-1554
38. Urpi-Sardá M., Jáuregui O., Lamuela-Raventós R.M., et al. Uptake of diet resveratrol into the human low-density lipoprotein. Identification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77 (2005) 3149-3155
39. Arendt B.M., Ellinger S., Kekic K., et al. Single and repeated moderate consumption of native or dealcoholized red wine show different effects on antioxidant parameters in blood and DNA strand breaks in peripheral leukocytes in healthy volunteers: a randomized controlled trial (ISRCTN68505294). J Nutr 4 (2005) 33
40. Duthie G.G., Pedersen M.W., Gardner P.T., et al. The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur J Clin Nutr 52 (1998) 733-736
41. Kiviniemi T.O., Saraste A., Toikka J.O., et al. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve. Atherosclerosis 195 (2007) 176-181
42. Caccetta R.A.A., Croft K.D., Beilin L.J., and Puckley I.B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidability. Am J Clin Nutr 71 (2000) 67-74
43. Ziegler S., Kostner K., Thallinger C., et al. Wine ingestion has no effect on lipid peroxidation products. Pharmacology 75 (2005) 152-156
44. Greenrod W., Stockley C.S., Burcham P., Abbey M., and Fenech M. Moderate acute intake of de-alcoholized red wine, but not alcohol, is protective against radiation-induced DNA damage ex vivo. Results of a comparative in vivo intervention study in younger men. Mut Res 591 (2005) 290-300
45. Ceriello A., Taboga C., Tonutti L., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106 (2002) 1211-1218
46. Maxwell S., Crickdhank A., and Thorpe G. Red wine and antioxidant activity in serum. Lancet 344 (1994) 193-194
47. Natella F., Ghiselli A., Guidi A., Ursini F., and Scaccini C. Red wine mitigates the postprandial increase of LDL susceptibility to oxidation. Free Radic Biol Med 30 (2001) 1036-1044
48. Ventura P., Bini A., Panini R., et al. Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers. Int J Vitam Nutr Res 74 (2004) 137-143
49. Gorelik S., Ligumsky M., Kohen R., and Kanner J. A novel function of red wine polyphenols in humans: prevention of absorption of cytotoxic lipid peroxidation products. FASEB J 22 (2008) 41-46
50. Ceriello A., Bortolotti N., Motz E., et al. Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest 3 (2001) 322-328
51. Blackhurst D.M., and Marais A.D. Concomitant consumption of red wine and polyunsaturated fat acids in edible oils does not influence the peroxidation status of chylomicron lipids despite increasing plasma catechin concentration. Nutr Met Cardiovasc Dis 16 (2006) 550-558
52. Nigdikar S.V., Williams N.R., Griffin B.A., and Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68 (1998) 258-265
53. Tsang C., Higgins S., Duthie G.G., et al. The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr 93 (2005) 233-240
54. Caccetta A.A.R., Burke V., Mori T.A., et al. Red wine polyphenols in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. Free Rad Biol Med 30 (2001) 636-642
55. Micallef M., Lexis L., and Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J (BioMed Central) 6 (2007) 27
56. Otaolaurruchi E., Fernández-Pachón M.S., González A.G., Troncoso A.M., and García-Parrilla M.C. Repeated red wine consumption and changes on plasma antioxidant capacity and endogenous antioxidants (uric acid and protein thiol groups). J Agric Food Chem 55 (2007) 9713-9716
57. Addolorato G., Leggio L., Ojetti V., et al. Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males. Appetite 50 (2008) 50-56
58. Guarda E., Godoy I., Foncea R., et al. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 104 (2005) 35-38
59. Marfella R., Cacciapuoti F., Siniscalchi M., et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabet Med 23 (2006) 974-981
60. Weinbrenner T., Cladellas M., Covas M.I., et al. High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 168 (2003) 99-106
61. Acín S., Navarro M.A., Arbonés-Mainar J.M., et al. Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J Biochem 140 (2006) 383-391
62. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?. Arch Biochem Biophys 476 (2008) 107-112
63. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 142 (2004) 231-255
64. Haliwell B. The wanderings of a free radical. Free Rad Biol Med 46 (2009) 531-542
65. Shimada K., Mokuno H., Matsunaga E., et al. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary heart disease. Atherosclerosis 174 (2004) 343-347
66. Blankenberg S., Rupprecht H.J., Bickel C., et al. AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary heart disease. New Engl J Med 349 (2003) 1605-1613
67. Sacanella E., Vázquez-Agell M., Mena M.P., et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 86 (2007) 1463-1469
68. Vázquez-Agell M., Sacanella E., Tobias E., et al. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 137 (2007) 2279-2284
69. Khansari N., Shakiba Y., and Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases. Recent Pat Inflamm Allergy Drug Discov 31 (2009) 73-80
70. Hongjun L., Colavitti R., Rovira I.I., and Finkel T. Redox-dependent transcriptional regulation. Cir Res 97 (2005) 967-974